• Molecular NameMimosine
  • SynonymL-Mimosine; Leucaenine; Leucaenol; Leucenine; Leucenol; Mimosin
  • Weight198.178
  • Drugbank_IDDB01055
  • ACS_NO500-44-7
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-3.87
  • pkaN/A
  • LogD (pH=7, predicted)-3.89
  • Solubility (experiment)Slightly soluble
  • LogS (predicted, ACD/Labs)(ph=7)-1.05
  • LogSw (predicted, AB/LogsW2.0)200.1
  • Sw (mg/ml) (predicted, ACD/Labs)14.36
  • No.of HBond Donors4
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds3
  • TPSA103.86
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyMimosine inhibits DNA synthesis at the level of elongation of nascent chains by altering deoxyribonucleotide metabolism. It arrests the cell cycle in the late G(1) phase.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding99.5
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A